Please assess the completion status of the following clinical trial:

Trial Title: Lutonix DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or non-pregnant female ≥18 years of age;~* Rutherford Clinical Category 3, 4 \& 5;~* Life expectancy ≥ 1 year;~* Significant stenosis (≥70%)~* A patent inflow artery;~* Target vessel(s) diameter between 2 and 4 mm;~* Target vessel(s) reconstitute(s) at or above the ankle~Exclusion Criteria:~* Pregnant or planning on becoming pregnant;~* History of stroke within 3 months;~* History of MI, thrombolysis or angina within 30 days of enrollment;~* Planned major amputation (of either leg)~* Prior major amputation if amputation occurred less than one year prior to enrollment and if patient is not independently ambulating;~* GFR ≤ 30 ml/min per 1.73m2;~* Acute limb ischemia;~* In-stent restenosis of target lesion

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Lutonix DCB (Type: EXPERIMENTAL): Lutonix Paclitaxel Drug Coated Balloon
- PTA Catheter (Type: ACTIVE_COMPARATOR): Standard Uncoated PTA Catheter

Based on this trial design, predict the completion outcome and termination type (if applicable).